← Open Payments lookup

MARK PEQUIGNOT: Open Payments

NPI 1770272148 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$380 in 21 payments from 11 companies in 2025. Trend: 2023 $137 · 2024 $330 · 2025 $380

Food & beverage: $380
CompanyPaymentsAmount
Novo Nordisk Inc7$126
Exact Sciences Corporation2$44
ABBVIE INC.2$40
Sumitomo Pharma America, Inc.2$35
Lilly USA, LLC2$32
Bayer Healthcare Pharmaceuticals Inc.1$21
Astellas Pharma US Inc1$19
Axsome Therapeutics, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: Ozempic, Wegovy, The Cologuard Plus Collection Kit, QULIPTA, GEMTESA, MOUNJARO, REXULTI, Kerendia.

Industry payments across OR — which companies pay providers there.